Dermatology

Filter

Hands affected by eczema showcasing redness and irritation after contact dermatitis in a neutral setting

Abrocitinib Shows Long-Term Success in Atopic Dermatitis

March 2026

Abrocitinib appears durable and well tolerated in patients with moderate-to-severe atopic dermatitis (AD), also known as eczema, according to a 2-year retrospective real-world study.

Hands affected by eczema showcasing redness and irritation after contact dermatitis in a neutral setting

Abrocitinib Shows Long-Term Success in Atopic Dermatitis

Abrocitinib appears durable and well tolerated in patients with moderate-to-severe atopic dermatitis (AD), also known as eczema, according to a 2-year retrospective real-world study.

Close-up of physician giving medication bottle to patient during consultation

Second-Line Pazopanib Yields Positive Responses in Angiosarcomas

Pazopanib shows activity and manageable safety in paclitaxel-pretreated cutaneous angiosarcoma, offering a potential second-line therapy option.

Patch testing for hand and foot eczema on a patient’s upper back with dermatology assessment

Hand and Foot Eczema Patch Testing Yields Few Positives

Patch testing in hand and foot eczema frequently showed no allergen, yet potassium dichromate topped positive results overall here.

Map showing global variation in skin-related neglected tropical diseases SDG progress and DALY trends to 2030

Global 2030 Goals Lag for Skin Neglected Tropical Diseases

Analysis finds 2030 skin-related neglected tropical diseases milestones off track as DALYs increase heterogeneously across nations.

Clinician reviewing eye imaging and notes, representing large language models in glaucoma clinical decision support

Large Language Models in Glaucoma Need Guardrails

Large language models in glaucoma show promise for education and decision support, yet performance varies widely.

Clinician reviewing GPT-4 learning models in dermatology output on a laptop

GPT-4 Learning Models in Dermatology Rated Poor

GPT-4 learning models in dermatology demonstrated substandard information yet rarely offered harmful advice in evaluation, overall.

Dermatologist assessing plaque psoriasis while reviewing roflumilast for psoriasis meta analysis results

Roflumilast for Psoriasis Shows Early Benefit

Roflumilast for psoriasis improved Global Assessment scores and was well tolerated versus placebo by Week 8 in a systematic review.

Dermatology exam lamp in clinic for plaque psoriasis care after vunakizumab discontinuation

Vunakizumab Discontinuation Predicts Plaque Psoriasis Remission

After vunakizumab discontinuation, many plaque psoriasis patients maintained PASI 90, but BMI and interruptions predicted relapses.

Loading posts...

1 2 3 … 22 Next »